NCT00003630View on ClinicalTrials.gov

Arsenic Trioxide in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1998

Primary Completion Date

August 31, 2000

Study Completion Date

August 31, 2000

Conditions
Unspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific
Interventions
DRUG

arsenic trioxide

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003630 - Arsenic Trioxide in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter